L
onge
C
ity
Advocacy & Research for Unlimited Lifespans
(Federation of American Societies for Experimental Biology) New research published in the March 2016 issue of The FASEB Journal, shows that a commonly prescribed class of high blood pressure drugs may have the potential to slow the growth of triple negative breast cancer tumors. These drugs, called 'beta blockers' work by counteracting the pro-growth effect caused by adrenaline by affecting the the beta2-adrenoceptor.
View the full article
